Skip to main content
Erschienen in: Journal of Neurology 5/2015

01.05.2015 | Original Communication

NEFL E396K mutation is associated with a novel dominant intermediate Charcot–Marie–Tooth disease phenotype

verfasst von: José Berciano, Antonio García, Kristien Peeters, Elena Gallardo, Els De Vriendt, Ana L. Pelayo-Negro, Jon Infante, Albena Jordanova

Erschienen in: Journal of Neurology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

The purpose of the study was to describe a pedigree with NEFL E396K mutation associated with a novel dominant intermediate Charcot–Marie–Tooth disease (DI-CMT) phenotype. The pedigree comprised four patients over two generations, aged between 35 and 59 years, who have been serially evaluated since 1993. Their clinical picture was characterized by pes cavus, sensorimotor neuropathy and spastic gait. Both older patients showed ascending leg weakness to involve pelvic musculature. CMT neuropathy score ranged from 14 to 26 (moderate to severe disease). Electrophysiology showed uniform nerve conduction slowing in the intermediate range, both in distal and proximal nerve segments. Multimodal evoked potential and blink reflex studies revealed abnormalities indicative of central sensorimotor pathway dysfunction. On imaging studies of lower-limb musculature, there was massive atrophy of intrinsic foot muscles and to a lesser degree of calves and thighs predominating in muscles innervated by tibial and sciatic nerves. In both patients exhibiting waddling gait, there was atrophy of pelvic muscles mainly involving gluteus medius, gluteus minimus and piriformis. We conclude that NEFL E396K mutation may manifest with a novel DI-CMT phenotype, characterized by simultaneous involvement of the peripheral and central nervous system.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280CrossRefPubMed Harding AE, Thomas PK (1980) The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 103:259–280CrossRefPubMed
2.
Zurück zum Zitat Davis CJ, Bradley WG, Madrid R (1978) The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 26:311–349PubMed Davis CJ, Bradley WG, Madrid R (1978) The peroneal muscular atrophy syndrome: clinical, genetic, electrophysiological and nerve biopsy studies. I. Clinical, genetic and electrophysiological findings and classification. J Genet Hum 26:311–349PubMed
3.
Zurück zum Zitat Madrid R, Bradley WG, Davis CJ (1977) The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies. J Neurol Sci 32:91–122CrossRefPubMed Madrid R, Bradley WG, Davis CJ (1977) The peroneal muscular atrophy syndrome. Clinical, genetic, electrophysiological and nerve biopsy studies. Part 2. Observations on pathological changes in sural nerve biopsies. J Neurol Sci 32:91–122CrossRefPubMed
4.
Zurück zum Zitat Bouché P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P (1983) Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 61:389–399CrossRefPubMed Bouché P, Gherardi R, Cathala HP, Lhermitte F, Castaigne P (1983) Peroneal muscular atrophy. Part 1. Clinical and electrophysiological study. J Neurol Sci 61:389–399CrossRefPubMed
5.
Zurück zum Zitat Nicholson G, Myers S (2006) Intermediate forms of Charcot–Marie–Tooth neuropathy: a review. Neuromolecular Med 8:123–130PubMed Nicholson G, Myers S (2006) Intermediate forms of Charcot–Marie–Tooth neuropathy: a review. Neuromolecular Med 8:123–130PubMed
6.
Zurück zum Zitat Rossor AM, Polke JM, Houlden H, Reilly MM (2013) Clinical implications of genetic advances in Charcot–Marie–Tooth disease. Nat Rev Neurol 9:562–571CrossRefPubMed Rossor AM, Polke JM, Houlden H, Reilly MM (2013) Clinical implications of genetic advances in Charcot–Marie–Tooth disease. Nat Rev Neurol 9:562–571CrossRefPubMed
7.
Zurück zum Zitat Nicholson G, Nash J (1993) Intermediate nerve conduction velocities define X-linked Charcot–Marie–Tooth neuropathy families. Neurology 43:2558–2564CrossRefPubMed Nicholson G, Nash J (1993) Intermediate nerve conduction velocities define X-linked Charcot–Marie–Tooth neuropathy families. Neurology 43:2558–2564CrossRefPubMed
8.
Zurück zum Zitat Liu L, Zhang R (2014) Intermediate Charcot–Marie–Tooth disease. Neurosci Bull 30:999–1009CrossRefPubMed Liu L, Zhang R (2014) Intermediate Charcot–Marie–Tooth disease. Neurosci Bull 30:999–1009CrossRefPubMed
9.
Zurück zum Zitat Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV (2009) A new variant of Charcot–Marie–Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67:37–46CrossRef Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV (2009) A new variant of Charcot–Marie–Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Genet 67:37–46CrossRef
10.
Zurück zum Zitat De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot–Marie–Tooth disease type 2E. Ann Neurol 49:245–249CrossRefPubMed De Jonghe P, Mersivanova I, Nelis E, Del Favero J, Martin JJ, Van Broeckhoven C, Evgrafov O, Timmerman V (2001) Further evidence that neurofilament light chain gene mutations can cause Charcot–Marie–Tooth disease type 2E. Ann Neurol 49:245–249CrossRefPubMed
11.
Zurück zum Zitat Georgiou DM, Zidar J, Korosec M, Middleton LT, Kyriakides T, Christodoulou K (2002) A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4:93–96CrossRefPubMed Georgiou DM, Zidar J, Korosec M, Middleton LT, Kyriakides T, Christodoulou K (2002) A novel NF-L mutation Pro22Ser is associated with CMT2 in a large Slovenian family. Neurogenetics 4:93–96CrossRefPubMed
12.
Zurück zum Zitat Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SCh, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot–Marie–Tooth disease. Brain 126:590–597CrossRefPubMed Jordanova A, De Jonghe P, Boerkoel CF, Takashima H, De Vriendt E, Ceuterick C, Martin JJ, Butler IJ, Mancias P, Papasozomenos SCh, Terespolsky D, Potocki L, Brown CW, Shy M, Rita DA, Tournev I, Kremensky I, Lupski JR, Timmerman V (2003) Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot–Marie–Tooth disease. Brain 126:590–597CrossRefPubMed
13.
Zurück zum Zitat Züchner S, Vorgerd M, Sindern E, Schröder JM (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot–Marie–Tooth neuropathy. Neuromuscul Disord 14:147–157CrossRefPubMed Züchner S, Vorgerd M, Sindern E, Schröder JM (2004) The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot–Marie–Tooth neuropathy. Neuromuscul Disord 14:147–157CrossRefPubMed
14.
Zurück zum Zitat Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, Rizzuto N (2007) Charcot–Marie–Tooth disease type 2E, a disorder of the cytoskeleton. Brain 130:394–403CrossRefPubMed Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, Rizzuto N (2007) Charcot–Marie–Tooth disease type 2E, a disorder of the cytoskeleton. Brain 130:394–403CrossRefPubMed
15.
Zurück zum Zitat Yum SW, Zhang J, Mo K, Li J, Scherer SS (2009) A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann Neurol 66:759–770PubMedCentralCrossRefPubMed Yum SW, Zhang J, Mo K, Li J, Scherer SS (2009) A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy. Ann Neurol 66:759–770PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Abe A, Numakura C, Saito K, Koide H, Oka N, Honma A, Kishikawa Y, Hayasaka K (2009) Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet 54:94–97CrossRefPubMed Abe A, Numakura C, Saito K, Koide H, Oka N, Honma A, Kishikawa Y, Hayasaka K (2009) Neurofilament light chain polypeptide gene mutations in Charcot–Marie–Tooth disease: nonsense mutation probably causes a recessive phenotype. J Hum Genet 54:94–97CrossRefPubMed
17.
Zurück zum Zitat Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, Löscher WN (2007) Clinical and electrophysiological features in Charcot–Marie–Tooth disease with mutations in the NEFL gene. Arch Neurol 64:966–970CrossRefPubMed Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, Löscher WN (2007) Clinical and electrophysiological features in Charcot–Marie–Tooth disease with mutations in the NEFL gene. Arch Neurol 64:966–970CrossRefPubMed
18.
Zurück zum Zitat Lin KP, Soong BW, Yang CC, Huang LW, Chang MH, Lee IH, Antonellis A, Lee YC (2011) The mutational spectrum in a cohort of Charcot–Marie–Tooth disease type 2 among the Han Chinese in Taiwan. PLoS One 6:e29393PubMedCentralCrossRefPubMed Lin KP, Soong BW, Yang CC, Huang LW, Chang MH, Lee IH, Antonellis A, Lee YC (2011) The mutational spectrum in a cohort of Charcot–Marie–Tooth disease type 2 among the Han Chinese in Taiwan. PLoS One 6:e29393PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME (2011) Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22–33PubMedCentralCrossRefPubMed Saporta AS, Sottile SL, Miller LJ, Feely SM, Siskind CE, Shy ME (2011) Charcot–Marie–Tooth disease subtypes and genetic testing strategies. Ann Neurol 69:22–33PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM, Castleman V, Manji H, Lunn MP, Bull K, Ramdharry G, Davis M, Blake JC, Houlden H, Reilly MM (2012) Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710PubMedCentralCrossRefPubMed Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM, Castleman V, Manji H, Lunn MP, Bull K, Ramdharry G, Davis M, Blake JC, Houlden H, Reilly MM (2012) Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry 83:706–710PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Sivera R, Sevilla T, Vílchez JJ, Martínez-Rubio D, Chumillas MJ, Vázquez JF, Muelas N, Bataller L, Millán JM, Palau F, Espinós C (2013) Charcot–Marie–Tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology 81:1617–1625PubMedCentralCrossRefPubMed Sivera R, Sevilla T, Vílchez JJ, Martínez-Rubio D, Chumillas MJ, Vázquez JF, Muelas N, Bataller L, Millán JM, Palau F, Espinós C (2013) Charcot–Marie–Tooth disease: genetic and clinical spectrum in a Spanish clinical series. Neurology 81:1617–1625PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 5:1061–1067CrossRef García A, Combarros O, Calleja J, Berciano J (1998) Charcot–Marie–Tooth disease type 1A with 17p duplication in infancy and early childhood: a longitudinal clinical and electrophysiologic study. Neurology 5:1061–1067CrossRef
23.
Zurück zum Zitat Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176PubMedCentralCrossRefPubMed Berciano J, Gallardo E, García A, Infante J, Mateo I, Combarros O (2006) Charcot–Marie–Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study. J Neurol Neurosurg Psychiatry 77:1169–1176PubMedCentralCrossRefPubMed
24.
Zurück zum Zitat Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214CrossRefPubMed Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M (2005) Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 64:1209–1214CrossRefPubMed
25.
Zurück zum Zitat García A, Pelayo-Negro AL, Alvarez-Paradelo S, Antolín FM, Berciano J (2015) Electromyographic tendon reflex recording: an accurate and comfortable method for diagnosis of Charcot–Marie–Tooth disease type 1A. Muscle Nerve. doi:10.1002/mus.24499 (Epub ahead of print) García A, Pelayo-Negro AL, Alvarez-Paradelo S, Antolín FM, Berciano J (2015) Electromyographic tendon reflex recording: an accurate and comfortable method for diagnosis of Charcot–Marie–Tooth disease type 1A. Muscle Nerve. doi:10.​1002/​mus.​24499 (Epub ahead of print)
26.
Zurück zum Zitat Chiappa KH (1997) Evoked potentials in clinical medicine, 3rd edn. Lippincott-Raven Press Publishers, Philadelphia-New York Chiappa KH (1997) Evoked potentials in clinical medicine, 3rd edn. Lippincott-Raven Press Publishers, Philadelphia-New York
27.
Zurück zum Zitat Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437CrossRefPubMed Gallardo E, García A, Combarros O, Berciano J (2006) Charcot–Marie–Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 129:426–437CrossRefPubMed
28.
Zurück zum Zitat Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, Van Loo P, Van Den Bossche M, Catthoor K, Sabbe B, Despierre E, Vergote I, Hilbush B, Lambrechts D, Del-Favero J (2011) Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol 18(30):61CrossRef Reumers J, De Rijk P, Zhao H, Liekens A, Smeets D, Cleary J, Van Loo P, Van Den Bossche M, Catthoor K, Sabbe B, Despierre E, Vergote I, Hilbush B, Lambrechts D, Del-Favero J (2011) Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing. Nat Biotechnol 18(30):61CrossRef
29.
Zurück zum Zitat McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297–1303PubMedCentralCrossRefPubMed McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo MA (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20:1297–1303PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Elbracht M, Senderek J, Schara U, Nolte K, Klopstock T, Roos A, Reimann J, Zerres K, Weis J, Rudnik-Schöneborn S (2014) Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot–Marie–Tooth disease type 2E. Clin Neuropathol 33:335–343CrossRefPubMed Elbracht M, Senderek J, Schara U, Nolte K, Klopstock T, Roos A, Reimann J, Zerres K, Weis J, Rudnik-Schöneborn S (2014) Clinical and morphological variability of the E396K mutation in the neurofilament light chain gene in patients with Charcot–Marie–Tooth disease type 2E. Clin Neuropathol 33:335–343CrossRefPubMed
32.
Zurück zum Zitat Hashiguchi A, Higuchi Y, Nomura M, Nakamura T, Arata H, Yuan J, Yoshimura A, Okamoto Y, Matsuura E, Takashima H (2014) Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs. J Peripher Nerv Syst 19:311–316CrossRefPubMed Hashiguchi A, Higuchi Y, Nomura M, Nakamura T, Arata H, Yuan J, Yoshimura A, Okamoto Y, Matsuura E, Takashima H (2014) Neurofilament light mutation causes hereditary motor and sensory neuropathy with pyramidal signs. J Peripher Nerv Syst 19:311–316CrossRefPubMed
33.
Zurück zum Zitat Buchthal F, Behse F (1977) Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 100:41–66CrossRefPubMed Buchthal F, Behse F (1977) Peroneal muscular atrophy (PMA) and related disorders. I. Clinical manifestations as related to biopsy findings, nerve conduction and electromyography. Brain 100:41–66CrossRefPubMed
35.
Zurück zum Zitat Leung CL, Nagan N, Graham TH, Liem RK (2006) A novel duplication/insertion mutation of NEFL in a patient with Charcot–Marie–Tooth disease. Am J Med Genet A 140:1021–1025CrossRefPubMed Leung CL, Nagan N, Graham TH, Liem RK (2006) A novel duplication/insertion mutation of NEFL in a patient with Charcot–Marie–Tooth disease. Am J Med Genet A 140:1021–1025CrossRefPubMed
36.
Zurück zum Zitat Agrawal PB, Joshi M, Marinakis NS, Schmitz-Abe K, Ciarlini PD, Sargent JC, Markianos K, De Girolami U, Chad DA, Beggs AH (2014) Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings. JAMA Neurol 71:1413–1420CrossRefPubMed Agrawal PB, Joshi M, Marinakis NS, Schmitz-Abe K, Ciarlini PD, Sargent JC, Markianos K, De Girolami U, Chad DA, Beggs AH (2014) Expanding the phenotype associated with the NEFL mutation: neuromuscular disease in a family with overlapping myopathic and neurogenic findings. JAMA Neurol 71:1413–1420CrossRefPubMed
37.
Zurück zum Zitat Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, Sunwoo IN, Kim NK, Chung KW (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot–Marie–Tooth neuropathy patients. Hum Mutat 24:185–186CrossRefPubMed Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, Sunwoo IN, Kim NK, Chung KW (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot–Marie–Tooth neuropathy patients. Hum Mutat 24:185–186CrossRefPubMed
38.
Zurück zum Zitat Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151–155CrossRefPubMed Cooper DN, Youssoufian H (1988) The CpG dinucleotide and human genetic disease. Hum Genet 78:151–155CrossRefPubMed
39.
Zurück zum Zitat Banchs I, Casasnovas C, Montero J, Volpini V, Martínez-Matos JA (2010) Charcot–Marie–Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene. Muscle Nerve 42:184–188CrossRefPubMed Banchs I, Casasnovas C, Montero J, Volpini V, Martínez-Matos JA (2010) Charcot–Marie–Tooth disease with intermediate conduction velocities caused by a novel mutation in the MPZ gene. Muscle Nerve 42:184–188CrossRefPubMed
40.
Zurück zum Zitat Shin JS, Chung KW, Cho SY, Yun J, Hwang SJ, Kang SH, Cho EM, Kim SM, Choi BO (2008) NEFL Pro22Arg mutation in Charcot–Marie–Tooth disease type 1. J Hum Genet 53:936–940CrossRefPubMed Shin JS, Chung KW, Cho SY, Yun J, Hwang SJ, Kang SH, Cho EM, Kim SM, Choi BO (2008) NEFL Pro22Arg mutation in Charcot–Marie–Tooth disease type 1. J Hum Genet 53:936–940CrossRefPubMed
41.
Zurück zum Zitat Lee SS, Lee HJ, Park JM, Hong YB, Park KD, Yoo JH, Koo H, Jung SC, Park HS, Lee JH, Lee MG, Hyun YS, Nakhro K, Chung KW, Choi BO (2013) Proximal dominant hereditary motor and sensory neuropathy with proximal dominance association with mutation in the TRK-fused gene. JAMA Neurol 70:607–615CrossRefPubMed Lee SS, Lee HJ, Park JM, Hong YB, Park KD, Yoo JH, Koo H, Jung SC, Park HS, Lee JH, Lee MG, Hyun YS, Nakhro K, Chung KW, Choi BO (2013) Proximal dominant hereditary motor and sensory neuropathy with proximal dominance association with mutation in the TRK-fused gene. JAMA Neurol 70:607–615CrossRefPubMed
42.
Zurück zum Zitat Shen H, Barry DM, Dale JM, Garcia VB, Calcutt NA, Garcia ML (2011) Muscle pathology without severe nerve pathology in a new mouse model of Charcot–Marie–Tooth disease type 2E. Hum Mol Genet 20:2535–2548PubMedCentralCrossRefPubMed Shen H, Barry DM, Dale JM, Garcia VB, Calcutt NA, Garcia ML (2011) Muscle pathology without severe nerve pathology in a new mouse model of Charcot–Marie–Tooth disease type 2E. Hum Mol Genet 20:2535–2548PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618CrossRefPubMed Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, Moon H, Park KD, Choi KG, Kim S, Kim SB, Shim DS, Kim SM, Sunwoo IN, Choi BO (2008) Different clinical and magnetic resonance imaging features between Charcot–Marie–Tooth disease type 1A and 2A. Neuromuscul Disord 18:610–618CrossRefPubMed
44.
Zurück zum Zitat Gaeta M, Mileto A, Mazzeo A, Minutoli F, Di Leo R, Settineri N, Donato R, Ascenti G, Blandino A (2012) MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot–Marie–Tooth type 2F disease. Skeletal Radiol 41:515–524CrossRefPubMed Gaeta M, Mileto A, Mazzeo A, Minutoli F, Di Leo R, Settineri N, Donato R, Ascenti G, Blandino A (2012) MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot–Marie–Tooth type 2F disease. Skeletal Radiol 41:515–524CrossRefPubMed
45.
Zurück zum Zitat Kamath S, Venkatanarasimha N, Walsh MA, Hughes PM (2008) MRI appearance of muscle denervation. Skeletal Radiol 37:397–404CrossRefPubMed Kamath S, Venkatanarasimha N, Walsh MA, Hughes PM (2008) MRI appearance of muscle denervation. Skeletal Radiol 37:397–404CrossRefPubMed
46.
Zurück zum Zitat Davis DV, Coupland RE (1967) Gray’s anatomy, Descriptive and applied. Longmans, Green & Co. LTD, London Davis DV, Coupland RE (1967) Gray’s anatomy, Descriptive and applied. Longmans, Green & Co. LTD, London
47.
Zurück zum Zitat Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T (2013) Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments. Pediatr Radiol 43:1327–1335CrossRefPubMed Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T (2013) Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments. Pediatr Radiol 43:1327–1335CrossRefPubMed
48.
Zurück zum Zitat Faridian-Aragh N, Wagner KR, Leung DG, Carrino JA (2014) Magnetic resonance imaging phenotyping of Becker muscular dystrophy. Muscle Nerve 50:962–967CrossRefPubMed Faridian-Aragh N, Wagner KR, Leung DG, Carrino JA (2014) Magnetic resonance imaging phenotyping of Becker muscular dystrophy. Muscle Nerve 50:962–967CrossRefPubMed
49.
Zurück zum Zitat de Visser M, Verbeeten B Jr (1985) Computed tomography of the skeletal musculature in Becker-type muscular dystrophy and benign infantile spinal muscular atrophy. Muscle Nerve 8:435–444CrossRefPubMed de Visser M, Verbeeten B Jr (1985) Computed tomography of the skeletal musculature in Becker-type muscular dystrophy and benign infantile spinal muscular atrophy. Muscle Nerve 8:435–444CrossRefPubMed
50.
Zurück zum Zitat De Pablos C, Berciano J, Calleja J (1991) Brain-stem auditory evoked potentials and blink reflex in Friedreich’s ataxia. J Neurol 238:212–216CrossRefPubMed De Pablos C, Berciano J, Calleja J (1991) Brain-stem auditory evoked potentials and blink reflex in Friedreich’s ataxia. J Neurol 238:212–216CrossRefPubMed
51.
Zurück zum Zitat Perrot R, Berges R, Bocquet A, Eyer J (2008) Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27–65CrossRefPubMed Perrot R, Berges R, Bocquet A, Eyer J (2008) Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27–65CrossRefPubMed
53.
Zurück zum Zitat Perez-Olle R, Leung CL, Liem RK (2002) Effects of Charcot–Marie–Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J Cell Sci 115:4937–4946CrossRefPubMed Perez-Olle R, Leung CL, Liem RK (2002) Effects of Charcot–Marie–Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. J Cell Sci 115:4937–4946CrossRefPubMed
54.
Zurück zum Zitat Pérez-Ollé R, López-Toledano MA, Goryunov D, Cabrera-Poch N, Stefanis L, Brown K, Liem RK (2005) Mutations in the neurofilament light gene linked to Charcot–Marie–Tooth disease cause defects in transport. J Neurochem 93:861–874CrossRefPubMed Pérez-Ollé R, López-Toledano MA, Goryunov D, Cabrera-Poch N, Stefanis L, Brown K, Liem RK (2005) Mutations in the neurofilament light gene linked to Charcot–Marie–Tooth disease cause defects in transport. J Neurochem 93:861–874CrossRefPubMed
55.
Zurück zum Zitat Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G, Martinuzzi A, Trabacca A, Losito L, Scarlato M, Benedetti S, Scarpini E, Spinicci G, Bresolin N, Bassi MT (2012) Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot–Marie–Tooth type 2. Clin Genet 82:157–164CrossRefPubMed Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G, Martinuzzi A, Trabacca A, Losito L, Scarlato M, Benedetti S, Scarpini E, Spinicci G, Bresolin N, Bassi MT (2012) Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot–Marie–Tooth type 2. Clin Genet 82:157–164CrossRefPubMed
56.
Zurück zum Zitat Adebola AA, Di Castri T, He C, Salvatierra LA, Zhao J, Brown K, Lin C, Worman HJ, Liem RK (2015) Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot–Marie–Tooth Type 2E phenotype. Hum Mol Genet 24:2163–2174 Adebola AA, Di Castri T, He C, Salvatierra LA, Zhao J, Brown K, Lin C, Worman HJ, Liem RK (2015) Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot–Marie–Tooth Type 2E phenotype. Hum Mol Genet 24:2163–2174
Metadaten
Titel
NEFL E396K mutation is associated with a novel dominant intermediate Charcot–Marie–Tooth disease phenotype
verfasst von
José Berciano
Antonio García
Kristien Peeters
Elena Gallardo
Els De Vriendt
Ana L. Pelayo-Negro
Jon Infante
Albena Jordanova
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 5/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7709-4

Weitere Artikel der Ausgabe 5/2015

Journal of Neurology 5/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.